生血宁片有效成分及其治疗肾性贫血的作用机制研究  

Study on the Active Components of Shengxuening Tablet and Its Mechanism in the Treatment of Renal Anemia

作　　者：汪月丹 尚飞[4] 方锦颖 张娇[1,2] 张子义 李文歌[1,2] WANG Yuedan;SHANG Fei;FANG Jinying;ZHANG Jiao;ZHANG Ziyi;LI Wenge(Beijing University of Traditional Chinese Medicine,Beijing 100029,China;China-Japan Friendship Hospital,Department of Nephrology,Beijing 100029,China;China-Japan Friendship Hospital,Deparment of International,Beijing 100029,China;Analysis and Testing Center,Beijing University of Chemical Technology,Beijing 100029,China)

机构地区：[1]北京中医药大学,北京100029 [2]中日友好医院肾病科,北京100029 [3]中日友好医院国际部,北京100029 [4]北京化工大学分析测试中心,北京100029

出　　处：《中国现代应用药学》2023年第11期1481-1489,共9页Chinese Journal of Modern Applied Pharmacy

摘　　要：目的 检测生血宁片主要化学成分,并预测其治疗肾性贫血的有效成分及潜在的作用机制。方法 根据甲醇提取液色谱质谱信息,并结合对照品的质谱碎片裂解规律和文献数据,对生血宁片化学成分进行鉴定;利用SwissTargetPrediction网站预测成分的作用靶点及GeneCards数据库收集肾性贫血相关靶点,获得交集靶点;通过String数据库构建蛋白相互作用网络及Metascape网站对交集靶点基因进行基因本体功能富集分析及KEGG通路富集分析,最后利用分子对接进一步分析。结果 通过UPLC-Q-TOF-MS技术共推测出生血宁片提取液中24个化学成分,其中9个为可能的活性成分,对应作用靶点363个;筛选出2 722个与肾性贫血相关的疾病靶点,疾病-药物交集靶点166个,涉及与肾性贫血相关的信号通路186条,通路主要与肿瘤、抗纤维化、炎症、氧反应等方面相关。分子对接结果显示,筛选的生血宁片活性成分西得罗、焦脱镁叶绿酸a、二甲基原卟啉IX二甲酯、31,32-二氢-脱镁叶绿酸盐a等与SRC、HSP90AA1、PIK3CA等潜在靶点之间结合力较强。结论 生血宁片可能通过补充铁元素、减轻炎症状态、抗纤维化等方面改善肾性贫血。OBJECTIVE To analyze the main chemical constituents and the potential molecular mechanism of Shengxuening tablets in treating renal anemia.METHODS The chemical constituents of Shengxuening tablets were identified according to the mass spectrometric fragment cleavage pattern.Swisstargetprediction website was used to screen the corresponding action targets of active components of Shengxuening tablets,and GeneCards database was used to screen related targets of renal anemia,getting intersection targets.String database was used to identify protein-protein interaction network.Genome ontology function enrichment analysis and KEGG pathway enrichment analysis of the target of Shengxuening tablets on renal anemia were performed through Metascape website.The above results were verified by molecular docking.RESULTS Twenty-four chemical constituents of Shengxuening tablets extract were analyzed by UPLC-Q-TOF-MS technology,among which nine were active components,corresponding to 363 targets.A total of 2722 disease targets related to renal anemia were retrieved,including 166 disease-drug intersection targets,186 pathways related to renal anemia,which were mainly related to cancer,anti-fibrosis,inflammation,oxygen response.Molecular docking results showed that siderol,pyrophaeophorbide a,dimethylprotoporphyrin IX dimethyl ester,31,32-dihydro-phaeophorbid-a could bind well with SRC,HSP90AA1,PIK3CA.CONCLUSION Shengxuening tablets may improve renal anemia by supplementing iron,improving inflammatory status and anti-fibrosis.

关 键 词：生血宁片 肾性贫血 UPLC-Q-TOF-MS 网络药理学 分子对接 

分 类 号：R284.1[医药卫生—中药学]